Immune effects of Lactobacillus casei Shirota in treated HIV-infected patients with poor CD4+ T-cell recovery.
- 2020-03-01
- RCT · n = 48
- AIDS (London, England) 34(3)
- Simone de Barros Tenore
- Vivian Iida Avelino-Silva
- Priscilla Ramos Costa
- Lucas M Franco
- Ester Cerdeira Sabino
- Jorge Kalil
- Natalia Barros Cerqueira
- Zelinda Nakagawa
- Esper Georges Kallas
- PubMed: 31714353
- DOI: 10.1097/qad.0000000000002420
- High evidence
- Clinical
We found no significant effects of LcS on ... sCD14 levels ... at week 12.
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- daily oral use